Please try another search
The fund primarily invests in pharmaceutical, medicine and biotechnology companies listed on leading European, American and Asian stock exchanges. The portfolio is well spread among different companies and countries. Since the funds investments are traded in currencies other than NOK, fluctuations in NOK exchange rates affect the value of the fund.
Name | Title | Since | Until |
---|---|---|---|
Rune Sand | - | 2020 | Now |
Biography | Mr. Sand joined DNB Asset Management (DNB AM) in 2020 as analyst for DNB AM’s Health Care fund. Between 2012 and 2020 he was a sell-side equity analyst covering the shipping sector at Carnegie (2012-2014) and Nordea (2014-2020) covering the shipping, real estate and construction sectors. Mr. Sand holds a M.Sc. in Finance from the Norwegian School of Management (BI). | ||
Benedicte Kilander Bakke | - | 2018 | Now |
Biography | Benedicte Bakke is portfolio manager for investments within healthcare. She started in DNB Asset Management in February in 2018. Before she started in Asset Management, she was working with financing of international healthcare companies in division Large Corporates International in DNB. Before Benedicte started in DNB in 2014, she has been working for the industry for 20 years with different roles for international pharmaceutical companies and smaller biotech companies. Benedicte has also had different board positions in listed and unlisted companies. She is a doctor of dental surgery and holds an MBA in cost and performance management from Norwegian School of Economics. | ||
Eirik Hernes Larsen | Investment Analyst | 2012 | 2021 |
Biography | Hernes Larsen is a portfolio manager responsible for global healthcare equities and is part of the global equity team. He joined the DNB in April 2012. He started his career as a financial analyst at First Securities in 2000 and later went to Carnegie, also as a financial analyst who covered Health care sector. In 2008 he started at Orkla ASA's investment division, where he was responsible for investments in technology and telecommunications. Hernes Larsen is a graduate of the Norwegian School of Management (BI). He is fluent in Norwegian and English. | ||
Knut Bakkemyr | - | 2017 | 2018 |
Biography | Knut Bakkemyr er forvalter for investeringer innen helsesektoren. Han startet i DNB Asset Management i mars 2017. Han startet sin karriere innenfor revisjon i PricewaterhouseCoopers i 2004. I 2006 begynte han i Selvaag Invest hvor han forvaltet investeringer innenfor børsnoterte aksjer og høyrenteobligasjoner. Knut Bakkemyr er utdannet siviløkonom fra Handelshøyskolen BI. Han snakker flytende norsk og engelsk. | ||
David DeMartino | - | 2009 | 2012 |
Biography | David DeMartino er porteføljeforvalter for globale aksjer innenfor helsesektoren. Før han startet i selskapet i 2006 dekket han helsesektoren som aksjeanalytiker for Credit Suisse First Boston på salg siden. Han startet sin karriere i 1998 på helseteamet på corporate siden i Deutche Bank Securities. Etter 5 år på corporate siden jobbet han to år som aksjeanalytiker på helsesektoren for samme selskap. DeMartino har en BA i økonomi fra Washington and Lee University. | ||
Thomas Mckeon | - | 2005 | 2009 |
Trond Horneland | - | 2003 | 2005 |
Per Henrik Græsberg | - | 2002 | 2003 |
Biography | Per-Henrik Græsberg er porteføljeforvalter for globale aksjer innenfor fornybar energi. Han startet i selskapet i 1990 og har jobbet med nordiske og internasjonale aksjer. Græsberg etablerte forsikringsselskapet Liv Kasko i 1987, som senere ble kjøpt opp av Vital. Fra 1986 til 1987 var han adm. direktor for Elcon Investment. Tidligere jobbet han for Fellesbanken. I løpet av perioden han jobbet i Fellesbanken, 1980 ¿ 1986, startet han og var fra 1983 adm. direktør for deres kapitalforvaltningsselskap Norsk Sparinvest. Græsberg startet sin karriere i 1977 på Universitetet i Karlstad hvor han underviste i statistikk. Han har en BA i økonomi, bedriftsøkonomi og statistikk, samt studier i oppvarmingsteknologi fra Universitetet i Göteborg. |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review